Role of nitric oxide and vascular endothelial growth factor in fluoride-induced goitrogenesis in rats

被引:22
作者
Liu, Guoyan [1 ,2 ]
Zhang, Weidong [1 ]
Jiang, Peng [1 ]
Li, Xinhong [1 ,2 ]
Liu, Chunyan [1 ]
Chai, Chunyan [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200240, Peoples R China
[2] Key Lab Shanghai Vet Biotech, Shanghai 200240, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluoride; Thyroid goiter; Nitric oxide; Vascular endothelial growth factor; Goitrogenesis; BIOLOGICAL-PROPERTIES; ANGIOGENESIS; SYNTHASE; EXPRESSION;
D O I
10.1016/j.etap.2012.04.003
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Endemic fluorosis is a serious problem in public health. Previous studies have indicated that patients with thyroid goiters usually live in fluoride-affected areas. However, the mechanism of goitrogenesis caused independently by fluoride is still unclear. The principle objective of this study was to investigate the possible roles of nitric oxide (NO) and vascular endothelial growth factor (VEGF) in the genesis of fluoride-induced nodular goiters. Eighty SD rats (40 males and 40 females) at the age of 4 weeks were used to establish animal models via fluoride-supplemented drinking water. These rats were randomly divided into four groups of 20. Group 1 was used as the control and were given deionized water. Group 2 (LF), group 3 (MF), and group 4 (HF) were given deionized water containing 50 mg/L, 100 mg/L, and 200 mg/L of sodium fluoride (NaF), respectively. Thyroid samples were collected on day 150. Pathological observation was performed to evaluate structural changes in the thyroid gland. The expression of VEGF mRNA in the thyroid glands was assessed by reverse transcriptional PCR. The serum NO level was analyzed by spectrometric methods. In addition, immunohistochemistry was conducted to evaluate expression and deposition of VEGF in the thyroid gland. The results showed that the average relative weight of the thyroid glands of rats in the fluoride-treated groups was significantly higher than that in control rats (p<0.05). The proliferation and dilatation of capillary blood vessels, enlarged follicles with excessive colloid, and obvious nodules were found in the thyroid glands of fluoride-treated rats. Compared to the control group, the expression of VEGF mRNA in the thyroid gland and the serum NO levels in the fluoride-treated groups were significantly increased (p<0.05). Furthermore, the deposition of VEGF in epithelial and follicular cells of the thyroid gland was significantly higher in fluoride-treated groups than in the control group. These results suggested that abnormal expression of VEGF induced by fluoride can lead to the proliferation of vascular endothelial cells in the thyroid gland. Accordingly, VEGF oversecreted locally by vascular endothelial cells might contribute to the proliferation of epithelial and follicular cells, resulting in the formation of hyperplastic nodules and enlargement of the thyroid gland. Furthermore, we proposed that there might be a positive feedback mechanism between NO and VEGF expression in fluoride-induced goiter formation. It was concluded that angiogenic and vasodilative factors such as VEGF and NO must be involved in fluoride-induced thyroid goitrogenesis. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 50 条
  • [21] Modulation of the effect of vascular endothelial growth factor on endothelial cells by heparin: Critical role of nitric oxide-mediated mechanisms
    Yague, S
    Arroyo, VA
    Castilla, A
    Pacheco, FRG
    Llamas, P
    Caramelo, C
    JOURNAL OF NEPHROLOGY, 2005, 18 (03) : 234 - 242
  • [22] Effects of valsartan on stress-induced changes of serum vascular endothelial growth factor and nitric oxide in mice
    Erbas, Bahar
    Uresin, Yagiz
    Ozek, Mehmet
    Dogru-Abbasoglu, Semra
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2006, 116 (05) : 601 - 611
  • [23] Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin
    E. Fujii
    Kaoru Irie
    Ken-ichi Ohba
    Akira Ogawa
    Toshimasa Yoshioka
    Mitsunori Yamakawa
    Takamura Muraki
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356 : 475 - 480
  • [24] Increased Nitric Oxide and Vascular Endothelial Growth Factor Levels in the Aqueous Humor of Patients with Coats' Disease
    Zhang, Han
    Liu, Zhe-Li
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (04) : 397 - 401
  • [25] Electrochemical study of the intracellular transduction of vascular endothelial growth factor induced nitric oxide synthase activity using a multi-channel biocompatible microelectrode array
    Trouillon, Raphael
    Cheung, Christine
    Patel, Bhavik Anil
    O'Hare, Danny
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2010, 1800 (09): : 929 - 936
  • [26] Angiostatin Inhibition of Vascular Endothelial Growth Factor-Stimulated Nitric Oxide Production in Endothelial Cells
    Takahashi, Satoru
    Shinya, Tomohiro
    Sugiyama, Akinori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 (04) : 432 - 437
  • [27] Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells
    Józkowicz, A
    Pankiewicz, J
    Dulak, J
    Partyka, L
    Wybranska, I
    Huk, I
    Dembinska-Kiec, A
    ACTA BIOCHIMICA POLONICA, 1999, 46 (03) : 703 - 715
  • [28] The correlation between nitric oxide and vascular endothelial growth factor in spinal cord injury
    Savas, S.
    Savas, C.
    Altuntas, I.
    Adiloglu, A.
    SPINAL CORD, 2008, 46 (02) : 113 - 117
  • [29] Induction of vascular endothelial growth factor by nitric oxide in cultured human articular chondrocytes
    Turpaev, K
    Litvinov, D
    Dubovaya, V
    Panasyuk, A
    Ivanov, D
    Prassolov, V
    BIOCHIMIE, 2001, 83 (06) : 515 - 522
  • [30] Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity
    Shihab, FS
    Bennett, WM
    Isaac, J
    Yi, H
    Andoh, TF
    KIDNEY INTERNATIONAL, 2003, 63 (02) : 522 - 533